Kenichi Akasaka Selected Research

Interferons

7/2021

Combination chemoradiotherapy with temozolomide, vincristine, and interferon-β might improve outcomes regardless of O6-methyl-guanine-DNA-methyltransferase (MGMT) promoter methylation status in newly glioblastoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kenichi Akasaka Research Topics

Disease

1	Glioblastoma (Glioblastoma Multiforme) 07/2021
1	Chronic Subdural Hematoma 01/2018
1	Intracranial Vasospasm 01/2018
1	Subarachnoid Hemorrhage (Aneurysmal Subarachnoid Hemorrhage) 01/2018
1	Brain Ischemia (Cerebral Ischemia) 01/2018
1	Infarction (Infarctions) 01/2018
1	Ruptured Aneurysm 01/2018

Drug/Important Bio-Agent (IBA)

1	Vincristine (Oncovin)FDA LinkGeneric 07/2021
1	Temozolomide (Temodar)FDA LinkGeneric 07/2021
1	InterferonsIBA 07/2021
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2018
1	pitavastatin (itavastatin)FDA Link 01/2018
1	oryeongsanIBA 01/2018

Therapy/Procedure

1	Therapeutics 07/2021
1	Chemoradiotherapy 07/2021